Skip to contentS
Skinvisible, Inc.
S
SKVISkinvisible, Inc. Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$5.00K$5.00Kderived±0.0% vs Q4 2023 Net Income$314.77K$314.77KderivedN/M vs Q4 2023 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Skinvisible, Inc. · CIK 1085277 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$5,000±0.0% Operating Incomederived-$198,743N/M Operating Cash Flowderived-$16,912N/M Free Cash Flowderived-$16,912— Margins · derivedGross margin100.0%±0.0 pt vs Q4 2023
Operating margin-3974.9%−1244.1 pt vs Q4 2023
Net margin6295.4%+12371.2 pt vs Q4 2023
ended Dec 31, 2024 · filed Apr 14, 2025 · 104 d after period end